Developer of a digital clinical diagnostics and drug discovery platform designed to offer oligonucleotides. The company's platform offers oligonucleotides which are short, single-stranded DNA, RNA or XNA molecules that can be developed with high affinity and specificity to any desirable targets and also offers bioaffinity products, enabling medical professionals to use those products for clinical diagnosis, environment and food safety monitoring and basic research.